Randomized Controlled Trials: Do They Have External Validity for Patients With Multiple Comorbidities?

Abstract

PURPOSE Many randomized controlled trials (RCTs) exclude patients who have multiple comorbidities. The aim of this study was to illustrate the prevalence of comorbidities among patients followed up in primary care who would have met the inclusion criteria of selected RCTs focusing on treatment of a particular condition. We used hypertension as an example of a particular chronic condition. METHODSWe used an existing database of 980 patients (660 women) that was representative of a population consulting primary care family doctors and that contained information about all chronic conditions. We randomly selected 5 RCTs that focused on patients with hypertension. The inclusion and exclusion criteria used in each of the 5 RCTs were applied (1 study at a time) to the patients in our database. The patients from our data set who met the inclusion criteria of a given RCT were considered eligible for that RCT. RESULTSOf the patients from our data set who were eligible for each of the RCTs, 89% to 100% had multiple chronic conditions. The mean number of chronic conditions of patients eligible for each RCT ranged from 5.5 ± 3.3 to 11.7 ± 5.3. CONCLUSIONSResults from this study suggest that RCTs targeting a chronic medical condition such as hypertension could fi nd that, in a sample taken from family practice, most eligible patients have comorbid conditions. Whether these patients are sampled or excluded should be reported. Research results intended to be applied in medical practice should take the complex reality of effective treatment of these patients into consideration.

Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?

“…33 Finally, it should not be forgotten that a large gap currently exists, on the part of professionals, in the availability of clinical guidelines and protocols that guide the management of patients with multimorbidity. 34 Physicians frequently find themselves deciding whether to apply criteria that, while adequate for each illness that a patient has, are not appropriate when the diseases are considered together. 4 Finding solutions to this problem has become a critical priority.…”

How Can Practice-based Research Contribute to the Elimination of Health Disparities?

“…Research designed to reduce or eliminate health disparities must focus on the complex mix of health disparities experienced by individual persons, not just isolated disease states. 60 In the North Karelia project cited above, the focus on reducing multiple behavioral risk factors all at the same time not only impacted cardiovascular deaths but later demonstrated similar declines in lung cancer deaths as a result of decreased smoking. 61 …”

Multimorbidity and Evidence Generation

“…21 Given the myriad ways that co-occurring chronic conditions might influence treatment effect, it should not be surprising that complex patients with multimorbidity are often excluded from clinical trials. [24][25][26] Such people may be excluded by the protocol both directly (via condition- specific exclusion criteria) or indirectly (e.g. through agerelated or treatment-related exclusion criteria).…”